Prior studies have implicated hyperactive mTOR signaling as a key driver of tumorigenic transformation in CRC via its potent activation of downstream effector proteins, p70S6K and 4EBP1 [41, 43]. This evidence concerns the gene RPS6KB1 and colorectal carcinoma.